DOTA-TRIS-TBU-ESTER NHS
819869-77-7
99%
CUIKANG
G/bottle,Kg/bag,25kg/barrel
2025-01-30
Cosmetics raw materials,Pesticide intermediate,Photoelectric material,pharmaceutical intermediates,Raw materials for food and health products,Polymer materials
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Tri-tert-butyl 2,2',2''-(10-(2-((2,5-dioxopyrrolidin-1-yl)oxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
Other Name:819869-77-7;DOTA-tris(tBu)ester NHS ester;Tri-tert-butyl 2,2',2''-(10-(2-((2,5-dioxopyrrolidin-1-yl)oxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate;tert-butyl 2-[7-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxoethyl]-4,10-bis[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;SCHEMBL3700587;DOTA tris(tBu)ester NHS ester;MFCD26131244;HY-131326;CS-0133217;A1-08303
CAS No.:819869-77-7
Molecular Formula:C32H55N5O10
InChIKeys:XIICJKXKEDCZEE-UHFFFAOYSA-N
Molecular Weight:669.8
Exact Mass:669.39489297
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Cosmetics raw materials,Pesticide intermediate,Photoelectric material,pharmaceutical intermediates,Raw materials for food and health products,Polymer materials
-
Location:
D307, Zhuque Square Office Building, No. 14, Chang'an North Road, Beilin District, Xi'an City, Shaanxi Province
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
45
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
Certifications:
ISO,ISO,ISO
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product